Pierre Palmer

1.5k total citations
30 papers, 890 citations indexed

About

Pierre Palmer is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Pierre Palmer has authored 30 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Pierre Palmer's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (5 papers). Pierre Palmer is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (5 papers). Pierre Palmer collaborates with scholars based in France, United States and United Kingdom. Pierre Palmer's co-authors include Pierre Lebon, S. Ravilly, Florence Moulin, D Gendrel, Jean‐Michel Molina, Josette Raymond, Claude Bohuon, Hervé Lefèvre, Joël Coste and Catherine Lacombe and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Pierre Palmer

29 papers receiving 843 citations

Peers

Pierre Palmer
Pierre Palmer
Citations per year, relative to Pierre Palmer Pierre Palmer (= 1×) peers Riccardo Raiteri

Countries citing papers authored by Pierre Palmer

Since Specialization
Citations

This map shows the geographic impact of Pierre Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Palmer more than expected).

Fields of papers citing papers by Pierre Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Palmer. The network helps show where Pierre Palmer may publish in the future.

Co-authorship network of co-authors of Pierre Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Palmer. A scholar is included among the top collaborators of Pierre Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Palmer. Pierre Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rachline, A., Pierre Palmer, François Simon, & Jean‐Michel Molina. (2010). Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg‐interferon and ribavirin in a patient co‐infected with HIV. Journal of Medical Virology. 82(7). 1150–1151. 2 indexed citations
2.
Coquet, Isaline, Juliette Pavie, Pierre Palmer, et al.. (2010). Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Critical Care. 14(3). R107–R107. 66 indexed citations
3.
Delaugerre, Constance, Blandine Denis, Gilles Peytavin, et al.. (2009). Clinical and Resistance Consequences of Misquantification of Plasma and Cerebrospinal Fluid Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Samples from an HIV-1 Subtype G-Infected Patient. Journal of Clinical Microbiology. 47(11). 3763–3764. 13 indexed citations
4.
Delaugerre, Constance, Juliette Pavie, Pierre Palmer, et al.. (2008). Pattern and impact of emerging resistance mutations in treatment experienced patients failing darunavir-containing regimen. AIDS. 22(14). 1809–1813. 20 indexed citations
5.
Costagliola, Dominique, Florence Damond, Pierre Palmer, Christine Rouzioux, & Françoise Brun‐Vézinet. (2008). One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?. AIDS. 22(15). 2042–2044. 3 indexed citations
6.
Chêne, Geneviève, Bahia Amellal, G. Pédrono, et al.. (2007). Changes in the Peripheral Blood mtDNA Levels in Naive Patients Treated by Different Nucleoside Reverse Transcriptase Inhibitor Combinations and Their Association with Subsequent Lipodystrophy. AIDS Research and Human Retroviruses. 23(1). 54–61. 8 indexed citations
7.
Molina, Jean‐Michel, Valérie Journot, Laurence Morand‐Joubert, et al.. (2005). Simplification Therapy with Once‐Daily Emtricitabine, Didanosine, and Efavirenz in HIV‐1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial. The Journal of Infectious Diseases. 191(6). 830–839. 51 indexed citations
8.
Masquelier, Bernard, Catherine Tamalet, Brigitte Montès, et al.. (2004). Genotypic Determinants of the Virological Response to Tenofovir Disoproxil Fumarate in Nucleoside Reverse Transcriptase Inhibitor-Experienced Patients. Antiviral Therapy. 9(3). 315–323. 30 indexed citations
9.
Bani‐Sadr, Firouzé, Pierre Palmer, Catherine Scieux, & Jean‐Michel Molina. (2004). Ninety‐Six–Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV‐1 and Wild‐Type Hepatitis B Virus. Clinical Infectious Diseases. 39(7). 1062–1064. 49 indexed citations
10.
Gennery, Andrew R., Anne M. Dickinson, D Barge, et al.. (2001). CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987–98 in a single center. Cytotherapy. 3(3). 221–232. 18 indexed citations
11.
Gouarin, S., Pierre Palmer, Denis Cointe, et al.. (2001). Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR. Journal of Clinical Virology. 21(1). 47–55. 62 indexed citations
12.
Palmer, Pierre, Bernard Charley, Bart Rombaut, Marc Daëron, & Pierre Lebon. (2000). Antibody-Dependent Induction of Type I Interferons by Poliovirus in Human Mononuclear Blood Cells Requires the Type II Fcγ Receptor (CD32). Virology. 278(1). 86–94. 52 indexed citations
13.
Gendrel, D, Pierre Palmer, E. Marc, et al.. (1999). Coïncidence des épidémies de rotavirus et de virus respiratoire syncytial à Paris : une enquête de 1993 à 1998. Archives de Pédiatrie. 6(7). 735–739. 26 indexed citations
14.
Gendrel, D, Josette Raymond, Joël Coste, et al.. (1999). Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. The Pediatric Infectious Disease Journal. 18(10). 875–881. 254 indexed citations
15.
Batteux, Frédéric, Pierre Palmer, Marc Daëron, Bernard Weill, & Pierre Lebon. (1999). FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.. PubMed. 10(4). 509–14. 47 indexed citations
16.
Muir, Peter, Paul E. Klapper, G.M. Cleator, et al.. (1999). Multicenter Quality Assessment of PCR Methods for Detection of Enteroviruses. Journal of Clinical Microbiology. 37(5). 1409–1414. 34 indexed citations
17.
Bouscary, Didier, C. Ginsburg, Pierre Palmer, et al.. (1998). [Acyclovir-resistance zona in a immunocompromised HIV seronegative patient].. PubMed. 125(2). 127–8. 1 indexed citations
18.
Palmer, Pierre, Flore Rozenberg, Jean François Meritet, & Pierre Lebon. (1997). Diagnostic anténatal des infections virales. Virologie. 1(5). 403–412.
19.
Palmer, Pierre, et al.. (1996). Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins. Clinical and Diagnostic Laboratory Immunology. 3(2). 236–238. 12 indexed citations
20.
Palmer, Pierre, et al.. (1973). Pure gonadal dysgenesis with bilateral gonadoblastomas.. PubMed. 42(2). 186–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026